Literature DB >> 26413871

IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.

Youjin Lee, Meike Mitsdoerffer, Sheng Xiao, Guangxiang Gu, Raymond A Sobel, Vijay K Kuchroo.   

Abstract

IL-17-producing CD4+ T cells (Th17 cells) have well-described pathogenic roles in tissue inflammation and autoimmune diseases, such as experimental autoimmune encephalomyelitis (EAE); however, the involvement of IL-21 in these processes has remained controversial. While IL-21 is an essential autocrine amplification factor for differentiation of Th17 cells, the loss of IL-21 or IL-21 receptor (IL-21R) does not protect mice from actively induced EAE. Here, we utilized a transgenic EAE mouse model, in which T and B cells overexpress receptors for myelin oligodendrocyte glycoprotein (MOG) (referred to as 2D2xTH mice), and demonstrated that IL-21 is critical for the development of a variant form of spontaneous EAE in these animals. Il21r deletion in 2D2xTH mice reduced the incidence and severity of spontaneous EAE, which was associated with a defect in Th17 cell generation. Moreover, IL-21R deficiency limited IL-23R expression on Th17 cells and inhibited expression of key molecules involved in the generation of pathogenic Th17 cells. Conversely, loss of IL-23R in 2D2xTH mice resulted in complete resistance to the development of spontaneous EAE. Our data identify a previously unappreciated role for IL-21 in EAE and reveal that IL-21-mediated signaling supports generation and stabilization of pathogenic Th17 cells and development of spontaneous autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26413871      PMCID: PMC4639966          DOI: 10.1172/JCI75933

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

Review 1.  Th17 and regulatory T cells in mediating and restraining inflammation.

Authors:  Dan R Littman; Alexander Y Rudensky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis.

Authors:  Jonathan M Coquet; Sumone Chakravarti; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 3.  B cells move to centre stage: novel opportunities for autoimmune disease treatment.

Authors:  Jeffrey L Browning
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

Review 4.  Neuromyelitis optica - Devic's syndrome, update.

Authors:  Raul N Mandler
Journal:  Autoimmun Rev       Date:  2006-03-21       Impact factor: 9.754

5.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

6.  Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

Authors:  Marc Veldhoen; Richard J Hocking; Richard A Flavell; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2006-09-24       Impact factor: 25.606

7.  Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Authors:  Yan Zheng; Dimitry M Danilenko; Patricia Valdez; Ian Kasman; Jeffrey Eastham-Anderson; Jianfeng Wu; Wenjun Ouyang
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

8.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.

Authors:  Roza Nurieva; Xuexian O Yang; Gustavo Martinez; Yongliang Zhang; Athanasia D Panopoulos; Li Ma; Kimberly Schluns; Qiang Tian; Stephanie S Watowich; Anton M Jetten; Chen Dong
Journal:  Nature       Date:  2007-06-20       Impact factor: 49.962

9.  IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.

Authors:  Thomas Korn; Estelle Bettelli; Wenda Gao; Amit Awasthi; Anneli Jäger; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2007-06-20       Impact factor: 49.962

10.  IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Authors:  Liang Zhou; Ivaylo I Ivanov; Rosanne Spolski; Roy Min; Kevin Shenderov; Takeshi Egawa; David E Levy; Warren J Leonard; Dan R Littman
Journal:  Nat Immunol       Date:  2007-06-20       Impact factor: 25.606

View more
  14 in total

1.  Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis.

Authors:  Mia Shapiro; Bisweswar Nandi; Gabriel Gonzalez; Rao H Prabhala; Hiroshi Mashimo; Qin Huang; Natasha Y Frank; Nikhil C Munshi; Jason S Gold
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

2.  IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge.

Authors:  Xinchun Zheng; Yang Zhou; Xuan Yi; Chengcong Chen; Chunhua Wen; Guofu Ye; Xiaoyi Li; Libo Tang; Xiaoyong Zhang; Fuqiang Yang; Guangze Liu; Yongyin Li; Jinlin Hou
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

Review 3.  IL-21 and T Cell Differentiation: Consider the Context.

Authors:  Yuan Tian; Allan J Zajac
Journal:  Trends Immunol       Date:  2016-07-04       Impact factor: 16.687

Review 4.  Sweet Rules: Linking Glycosylation to Antibody Function.

Authors:  Falk Nimmerjahn; Anja Werner
Journal:  Exp Suppl       Date:  2021

5.  Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis.

Authors:  Miguel Chillón; Carmen Espejo; Ángel Edo; Laura Calvo-Barreiro; Herena Eixarch; Assumpció Bosch
Journal:  Neurotherapeutics       Date:  2022-07-28       Impact factor: 6.088

6.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

7.  Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells.

Authors:  Ying Wang; Li-Li Wang; Hao-Yu Yang; Fei-Fei Wang; Xue-Xiu Zhang; Yan-Ping Bai
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

8.  A Context-Dependent Role for IL-21 in Modulating the Differentiation, Distribution, and Abundance of Effector and Memory CD8 T Cell Subsets.

Authors:  Yuan Tian; Maureen A Cox; Shannon M Kahan; Jennifer T Ingram; Rakesh K Bakshi; Allan J Zajac
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

Review 9.  Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review.

Authors:  Katja Schmitz; Gerd Geisslinger; Irmgard Tegeder
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

10.  Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.

Authors:  Malav S Trivedi; Elisa Oltra; Leonor Sarria; Natasha Rose; Vladimir Beljanski; Mary Ann Fletcher; Nancy G Klimas; Lubov Nathanson
Journal:  PLoS One       Date:  2018-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.